BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27571049)

  • 1. Screening of drug metabolizing enzymes for fusidic acid and its interactions with isoform-selective substrates in vitro.
    Chen D; Lin XX; Zhao Q; Xiao J; Peng SF; Xiao MF; Ouyang DS; Tan ZR; Wang YC; Peng JB; Zhang W; Chen Y
    Xenobiotica; 2017 Sep; 47(9):778-784. PubMed ID: 27571049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium tanshinone IIA sulfonate and its interactions with human CYP450s.
    Chen D; Lin XX; Huang WH; Zhang W; Tan ZR; Peng JB; Wang YC; Guo Y; Hu DL; Chen Y
    Xenobiotica; 2016 Dec; 46(12):1085-1092. PubMed ID: 26932161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
    Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH
    Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San.
    Huang X; Guo Y; Huang WH; Zhang W; Tan ZR; Peng JB; Wang YC; Hu DL; Ouyang DS; Xiao J; Wang Y; Luo M; Chen Y
    PLoS One; 2014; 9(11):e113819. PubMed ID: 25427198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng.
    Xiao J; Chen D; Lin XX; Peng SF; Xiao MF; Huang WH; Wang YC; Peng JB; Zhang W; Ouyang DS; Chen Y
    PLoS One; 2016; 11(2):e0147183. PubMed ID: 26845774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
    Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
    J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
    Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
    Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti-inflammatory drug, and its lack of clinically significant CYP inhibition potential.
    Furuta S; Akagawa N; Kamada E; Hiyama A; Kawabata Y; Kowata N; Inaba A; Matthews A; Hall M; Kurimoto T
    Br J Clin Pharmacol; 2002 Sep; 54(3):295-303. PubMed ID: 12236850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
    Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
    Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potent mechanism-based inactivation of CYP2D6 and CYP3A4 with fusidic acid in in vivo bioaccumulation.
    Lin XX; Lian GH; Xu Y; Zhao Q; Xiao J; Peng SF; Xiao MF; Ouyang DS; Tan ZR; Wang YC; Peng JB; Zhang W; Chen Y
    Xenobiotica; 2018 Oct; 48(10):999-1005. PubMed ID: 29027845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
    He X; Luo X; Liu Z; Hu G; Cheng Z
    Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
    Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro.
    Ouyang DS; Huang WH; Chen D; Zhang W; Tan ZR; Peng JB; Wang YC; Guo Y; Hu DL; Xiao J; Chen Y
    Chin Med; 2016; 11():11. PubMed ID: 27006687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of cytochrome P450 2D6 by Sarpogrelate and its active metabolite, M-1, in human liver microsomes.
    Cho DY; Bae SH; Lee JK; Kim YW; Kim BT; Bae SK
    Drug Metab Dispos; 2014 Jan; 42(1):33-9. PubMed ID: 24167220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
    Rastogi H; Jana S
    Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cytochrome P450s involved in the metabolism of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1) using human recombinant enzymes and rat liver microsomes in vitro.
    Lu YY; Cheng HX; Wang X; Wang XW; Liu JY; Li P; Lou YQ; Li J; Lu C; Zhang GL
    Xenobiotica; 2017 Aug; 47(8):667-672. PubMed ID: 27910729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
    Jin SE; Seo CS; Shin HK; Ha H
    Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.